Scopus Eşleşmesi Bulundu
23
Atıf
20
Cilt
972-976
Sayfa
🔓
Açık Erişim
Scopus Yazarları: M. Ceyhan, Nezahat Gurler, Gulnar Sensoy, Mustafa Hacımustafaoğlu, Yasemin Ozsurekci, Sengul Ozkan, Nursen Belet, Solmaz Çelebi, Ener Cagri Dinleyici, A. Baki, Hakan Uzun, Ahmet Emre Aycan, Eda Karadag Oncel, Melike Emiroglu, Zafer Kurugöl, Venhar Gurbuz, Aslinur Ozkaya Parlakay, Emre Alhan, A. F. Oner, Melda Celik
Özet
Streptococcus pneumoniae is the most common etiological cause of complicated pneumonia, including empyema. In this study, we investigated the serotypes of S. pneumoniae that cause empyema in children. One hundred fifty-six children who were diagnosed with pneumonia complicated with empyema in 13 hospitals in seven geographic regions of Turkey between 2010 and 2012 were included in this study. Pleural fluid samples were collected by thoracentesis and tested for 14 serotypes/serogroups using a Bio-Plex multiplex antigen detection assay. The serotypes of S. pneumoniae were specified in 33 of 156 samples. The mean age ± the standard deviation of the 33 patients was 6.17 ± 3.54 years (range, 0.6 to 15 years). All of the children were unvaccinated according to the vaccination reports. Eighteen of the children were male, and 15 were female. The serotypes of the non-7-valent pneumococcal conjugated vaccine (non-PCV-7), serotype 1, serotype 5, and serotype 3, were detected in eight (14.5%), seven (12.7%), and five (9.1%) of the samples, respectively. Serotypes 1 and 5 were codetected in two samples. The remaining non- PCV-7 serotypes were 8 (n = 3), 18 (n = 1), 19A (n = 1), and 7F/A (n = 1). PCV-7 serotypes 6B, 9V, 14, 19F, and 23F were detected in nine (16.3%) of the samples. The potential serotype coverages of PCV-7, PCV-10, and PCV-13 were 16.3%, 45.4%, and 60%, respectively. Pediatric parapneumonic empyema continues to be an important health problem despite the introduction of conjugated pneumococcal vaccines. Active surveillance studies are needed to monitor the change in S. pneumoniae serotypes that cause empyema in order to have a better selection of pneumococcal vaccines. Copyright © 2013, American Society for Microbiology. All Rights Reserved.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2013 yılı verileri
Clinical and Vaccine Immunology
Q1
SJR Quartile
1,258
SJR Skoru
95
H-Index
Kategoriler: Clinical Biochemistry (Q1) · Medicine (miscellaneous) (Q1) · Microbiology (medical) (Q1) · Immunology (Q2) · Immunology and Allergy (Q2)
Alanlar: Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine
Ülke: United States
· American Society for Microbiology
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Makale Bilgileri
Dergi
Clinical and Vaccine Immunology
ISSN
1556-6811
Yıl
2013
/ 5. ay
Cilt / Sayı
20
/ 7
Sayfalar
972 – 976
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
Yayın Dili
İngilizce
Kapsam
Uluslararası
Toplam Yazar
20 kişi
Erişim Türü
Elektronik
Erişim Linki
Makaleye Git
Alan
Sağlık Bilimleri Temel Alanı-
Enfeksiyon Hastalıkları (Çocuk Sağlığı ve Hastalıkları)
YÖKSİS Yazar Kaydı
Yazar Adı
CEYHAN MEHMET,ÖZSÜREKCİ YASEMİN,GÜRLER NEZAHAT,ŞENGÜL Özkan,ŞENSOY SEMA GÜLNAR,BELET NURŞEN,HACIMUSTAFAOĞLU MUSTAFA KEMAL,ÇELEBİ SOLMAZ,EMİROĞLU MELİKE,DİNLEYİCİ ENER ÇAĞRI,Alhan Emre,BAKİ ALİ ERDEM,Öner A HMET FAİK,Uzun HAKAN,KURUGÖL NURİ ZAFER,AYCAN AHMET EMRE,GÜRBÜZ VENHAR,KARADAĞ ÖNCEL EDA,ÇELİK MELDA,PARLAKAY ÖZKAYA ASLINUR
YÖKSİS ID
4550580
Hızlı Erişim
Metrikler
Scopus Atıf
23
Yazar Sayısı
20